AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (862.8 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Jing Tanga,b,c,1, Yue Lia,b,c,1, Jiazhu Wua,b,c, Haorui Shena,b,c, Hua Yina,b,c, Jinhua Lianga,b,c, Li Wanga,b,c, Jianyong Lia,b,c, Yi Xiaa,b,c( ), Wei Xua,b,c( )
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China
Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu 210029, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu 210029, China

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 11 Issue 2,
March 2024
Pages 550-553
DOI: 10.1016/j.gendis.2023.04.012

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Tang J, Li Y, Wu J, et al. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma. Genes & Diseases, 2024, 11(2): 550-553. https://doi.org/10.1016/j.gendis.2023.04.012

625

Views

8

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD
Received: 09 December 2022
Published: 18 May 2023
© 2023 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).